SILOSilo Pharma, Inc.vs its industry peers
A metric-by-metric comparison of Silo Pharma, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SILO본 종목 | $2M#8 | 0.4x#7 | 0.4x#7 | 27.4x#8 | 0.0%#2 | 3.8%#10 | -5937.0%#8 | -86.5%#2 | — | — | — | — |
| BFRGW | $3M#1 | — | 0.4x#5 | 22.2x#7 | — | 7.1%#8 | -5652.4%#7 | -93.0%#3 | -5287.3%#3 | — | — | — |
| APVO | $2M#2 | 0.0x#2 | 0.4x#6 | 0.8x#3 | -74.7%#7 | -7.6%#11 | -845.0%#3 | -429.8%#9 | — | — | -95.1%#3 | — |
| ZVSA | $2M#3 | — | — | — | — | -165.1%#14 | — | — | — | — | — | — |
| KPTI | $2M#4 | — | — | 0.0x#1 | 0.6%#1 | -156.5%#13 | -62.1%#1 | — | — | — | — | — |
| HCWB | $2M#5 | 0.0x#5 | 0.3x#4 | 40.0x#9 | -97.9%#8 | 73.5%#4 | -24270.7%#9 | -107.2%#5 | -99.4%#1 | 3#2 | — | — |
| ONCO | $2M#6 | 0.0x#1 | 0.2x#2 | 2.6x#5 | -67.7%#5 | 76.1%#2 | -2190.0%#6 | -104.2%#4 | — | — | — | — |
| BIVIW | $2M#7 | — | 0.2x#3 | — | — | -25.8%#12 | — | -214.9%#8 | -1671.2%#2 | — | -19.7%#1 | — |
| GNPX | $2M#9 | 0.0x#3 | 0.1x#1 | — | — | 24.1%#5 | — | -109.7%#6 | — | — | — | — |
| JUNS | $2M#10 | — | — | 82.7x#11 | — | -254.4%#15 | -40873.2%#11 | — | — | — | -97.8%#4 | — |
| OGEN | $2M#11 | 0.4x#6 | 0.5x#9 | 44.6x#10 | -71.4%#6 | 6.9%#9 | -24865.2%#10 | -26814.1%#12 | — | — | — | — |
| ATXI | $1M#12 | — | 2.4x#12 | 1.0x#4 | — | 75.0%#3 | -219.6%#2 | -511.2%#10 | — | — | — | — |
| PTIX | $1M#13 | 0.5x#8 | 0.8x#11 | — | — | 138.1%#1 | — | 79.4%#1 | — | — | -70.4%#2 | — |
| GOVX | $1M#14 | — | 0.7x#10 | 0.5x#2 | -37.1%#4 | 14.1%#7 | -869.3%#4 | -1219.1%#11 | — | — | — | — |
| NXTS | $857466#15 | 0.0x#4 | 0.5x#8 | 4.1x#6 | -20.2%#3 | 22.9%#6 | -2014.3%#5 | -210.2%#7 | — | 4#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice